37
Sofinnova BioEquities Enhanced Offshore Fund Ltd. updates its Form D — $226.3M sold
Fund raise update · Hedge fund · Open-ended · Offering Indefinite · Sold $226.3M · Grand Cayman, Cayman Islands · filed 2025-10-10
3(c)(7) — qualified purchasers
37
Sofinnova BioEquities Enhanced Offshore Fund files amendment after raising $226.25M
Fund raise update · Hedge fund · Open-ended · Grand Cayman, Cayman Islands · Form D/A filed 2026-10-09 · sponsor: Sofinnova Investments · all Sofinnova Bioequities Enhanced vehicles
Sofinnova BioEquities Enhanced Offshore Fund Ltd., a Cayman Islands hedge fund, has raised $226.25M from institutional investors under Regulation D exemption 3(c)(7). The fund launched in October 2022 and operates with a $100K minimum investment.
Note: Filing is an amendment (D/A) to an existing offering; fund incorporated in 2022 with first sale in October 2022.
$100M+ sold3(c)(7) — qualified purchasersHedge fund
Why now — by persona
- Fund audit & tax:A concrete reason to call this issuer this week, citing the filing. Subscribe to unlock
- Fund administrator:A concrete reason to call this issuer this week, citing the filing. Subscribe to unlock
People on the filing
| -- Sofinnova Investments, Inc. | Investment Manager |
| Eric Delbridge | Director |
| Cary Marr | Director |
| Paul Stevenson | Director |
Signed by Jim Brody, Chief Compliance Officer.
Filing contact
The issuer's phone number and address from the filing are shown to subscribers. See plans, or read it on EDGAR.
Other filings by this issuer
37
Sofinnova BioEquities Enhanced Offshore Fund Ltd. updates its Form D — $226.3M sold
Fund raise update · Hedge fund · Open-ended · Offering Indefinite · Sold $226.3M · GRAND CAYMAN, CA · filed 2024-10-11
3(c)(7) — qualified purchasers